RAPS announces the 2022 Fellows Program recipients

• Kimberly Belsky, FRAPS, MS, Executive Director, Regulatory Policy & Intelligence and AdPromo, Mallinckrodt Pharmaceuticals 

• Paul C. Brooks, FRAPS, Retired 

• Monique J. Carter, FRAPS, MS, RAC-US, Senior Director and Global Regulatory Lead, Pfizer 

• Niedre M. Heckman, FRAPS, PhD, MPH, RAC-US, RAC-EU, ASQ-CQA, Director, Global Regulatory Affairs, Takeda 

• Aman Khera, Vice President, FRAPS, Global Head, Regulatory Strategy, Worldwide Clinical Trials 

• Melissa O'Connor, FRAPS, RAC-US, CTBS, Chief Quality & Regulatory Officer, StimLabs, LLC 

• Grace Powers, FRAPS, RAC-US, RAC-EU, RAC-Global, Founder/ Principal Consultant, Powers Regulatory Consulting 

• Raymond Seda, FRAPS, RAC-US, Senior Director, Global QMS Operations, Medtronic 

• Amie Smirthwaite, FRAPS, BEng, PhD, Senior VP, Intelligence and Innovation, RQM+ 

• Sylvie Laliberté Verdon, FRAPS, MS, RAC-US, RAC-Canada, MPM®, Director of Regulatory Affairs, North America, HTL-Strefa, Inc.

To become a RAPS Fellow, one must be a proven leader who has demonstrated distinct dedication to the regulatory profession with a history of commitment and success. Professionals who are selected to the program receive the FRAPS designation and are acknowledged during RAPS Convergence, the largest annual conference dedicated to healthcare product regulation and regulatory issues. This year's event occurs 11-13 September in Phoenix, AZ.

“The honor of being named a RAPS Fellow is reserved for those outstanding regulatory leaders who not only excel in the field, but who also go above and beyond to give back to the profession, their peers, and future generations of regulatory professionals,” said RAPS Interim Executive Director and COO Bill McMoil. “RAPS and the global regulatory community are enriched by the involvement of these distinguished leaders and advocates.”

More information about the Fellows program, application process and selection criteria can be found at www.raps.org/membership/raps-fellows.